- About Us
About Us
Founded in 2004, DIURNAL®, a NEUROCRINE BIOSCIENCES® Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency.
- Research
Research
Our expertise and innovative research activities focus on circadian-based endocrinology (mimicking the body's natural hormone levels) to develop products for rare and chronic endocrine conditions
- Information for patients
Information for patients
This section is a resource providing information on Diurnal medicines available in the UK. It is not intended to replace the advice of a qualified doctor.
- Transparency
Transparency
Diurnal is committed to transparency in its interactions. Diurnal commits to following the Association of British Pharmaceutical Industry (ABPI) Code of Practice which has clear requirements for transparency.
- Careers
Careers
Diurnal is a rapidly growing global specialty pharmaceutical company with a highly integrated and very committed team. We're always looking for talented individuals who share our vision. Visit this section to view our current opportunities.
UK laws and regulations limit the amount of product information that we can provide to the public on our website, the information here is intended for patients treated with Alkindi and their carers.
Alkindi Patient Information
This page is specifically intended to support UK patients who have been prescribed Alkindi by their doctor. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the Patient Information Leaflet provided with your medicine and which is reproduced here. Click here to see the Alkindi Patient Information Leaflet
Alkindi - Administration video
This video is intended for patients who have been prescribed Alkindi and provides a step-by-step administration guide.
Adverse events should be reported Reporting Forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse Events should also be reported to Diurnal on adverse-events@diurnal.co.uk